Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Pauschinger

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Circulation|August 2, 2006
Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditisStephane Heymans, Matthias Pauschinger, Armando De Palma, et al.
Journal of the American College of Cardiology|April 25, 2009
Cardiovascular magnetic resonance in myocarditis: A JACC White PaperMatthias G Friedrich, Udo Sechtem, Jeanette Schulz-Menger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
First-line trastuzumab plus epirubicin and cyclophosphamide therapy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: cardiac safety and efficacy data from the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) trialMichael Untch, Michael Muscholl, Sergei Tjulandin, et al.
European Journal of Heart Failure|March 2, 2026
Balancing blood pressure and catecholamine support is critical in heart failure-related cardiogenic shock patientsBenedikt N Beer, Caroline Kellner, Jonas Sundermeyer, et al.
European Journal of Heart Failure|October 24, 2024
Timing of veno-arterial extracorporeal membrane oxygenation support in patients with cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
Internal and Emergency Medicine|November 19, 2025
Troponin predicts mortality in heart failure-related cardiogenic shockBenedikt N Beer, Jonas Sundermeyer, Lisa Besch, et al.
JACC. Heart Failure|February 1, 2023
Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation TherapyBenedikt Schrage, Jonas Sundermeyer, Stefan Blankenberg, et al.
Circulation|December 28, 2018
Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic ShockBenedikt Schrage, Karim Ibrahim, Tobias Loehn, et al.
European Journal of Heart Failure|January 17, 2025
Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shockAngela Dettling, Caroline Kellner, Jonas Sundermeyer, et al.
European Journal of Heart Failure|February 13, 2023
Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shockBenedikt Schrage, Jonas Sundermeyer, Benedikt Norbert Beer, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Circulation|August 2, 2006
Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditisStephane Heymans, Matthias Pauschinger, Armando De Palma, et al.
Journal of the American College of Cardiology|April 25, 2009
Cardiovascular magnetic resonance in myocarditis: A JACC White PaperMatthias G Friedrich, Udo Sechtem, Jeanette Schulz-Menger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2010
First-line trastuzumab plus epirubicin and cyclophosphamide therapy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: cardiac safety and efficacy data from the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) trialMichael Untch, Michael Muscholl, Sergei Tjulandin, et al.
European Journal of Heart Failure|March 2, 2026
Balancing blood pressure and catecholamine support is critical in heart failure-related cardiogenic shock patientsBenedikt N Beer, Caroline Kellner, Jonas Sundermeyer, et al.
European Journal of Heart Failure|October 24, 2024
Timing of veno-arterial extracorporeal membrane oxygenation support in patients with cardiogenic shockJonas Sundermeyer, Caroline Kellner, Benedikt N Beer, et al.
Internal and Emergency Medicine|November 19, 2025
Troponin predicts mortality in heart failure-related cardiogenic shockBenedikt N Beer, Jonas Sundermeyer, Lisa Besch, et al.
JACC. Heart Failure|February 1, 2023
Timing of Active Left Ventricular Unloading in Patients on Venoarterial Extracorporeal Membrane Oxygenation TherapyBenedikt Schrage, Jonas Sundermeyer, Stefan Blankenberg, et al.
Circulation|December 28, 2018
Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic ShockBenedikt Schrage, Karim Ibrahim, Tobias Loehn, et al.
European Journal of Heart Failure|January 17, 2025
Incidence and predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation therapy in patients with cardiogenic shockAngela Dettling, Caroline Kellner, Jonas Sundermeyer, et al.
European Journal of Heart Failure|February 13, 2023
Use of mechanical circulatory support in patients with non-ischaemic cardiogenic shockBenedikt Schrage, Jonas Sundermeyer, Benedikt Norbert Beer, et al.
Pageof 12